IP Library Granted Patent US 11,911,585
Granted Patent B2
US 11,911,585 · App. 16/039,943 · Granted Feb 27, 2024

Methods and systems for coupling conduits

Inventors: John Hall (North Salt Lake, UT); Wayne Mower (Bountiful, UT)
Assignee: Merit Medical Systems, Inc.
A61M39/10A61B17/00A61B17/11A61M1/3655A61M39/0247A61M39/04A61M39/12A61M39/14A61B2017/00477A61B2017/00685A61B2017/1107A61B2017/1132A61M2039/0258A61M2039/0273A61M2039/087
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,911,585
App. No.
16/039,943
Granted
Feb 27, 2024
Kind
B2
Abstract

Medical devices including vascular access kits and related methods are disclosed. In some embodiments, a vascular access system may include a first conduit, a second conduit, and a connector that is reversibly or irreversibly coupled to both the first and second conduits such that there is a continuous lumen from the first conduit and the second conduit. In some embodiments the vascular access system may include a connector where the inside geometry of the connector enhances laminar flow. The vascular access system, when implanted and assembled, may be a fully subcutaneous surgical implant.

Claims (45)

1. A vascular access system, comprising:

a first conduit;

a second conduit; and

a connector comprising an inside luminal wall, a first end, a second end, a first connecting member on the first end, and a second connecting member on the second end,

the connector being configured to couple to an end of the first conduit and to an end of the second conduit such that there is a continuous lumen from the first conduit to the second conduit, wherein the connector is configured to irreversibly couple to at least one of the first conduit and the second conduit,

wherein both the first and second connecting members further comprise a hinge,

wherein the connector comprises a flange disposed between the first end and the second end,

wherein the connector comprises a first circumferential ridge disposed on the first end adjacent the flange and a second circumferential ridge disposed on the second end adjacent the flange,

wherein each of the first and second circumferential ridges comprise a shoulder facing toward the flange,

wherein the first connecting member and the second connecting member each comprise a radially inwardly extending protrusion adjacent to the flange and comprising a shoulder facing away from the flange,

wherein at least a portion of the first conduit is disposed between the shoulder of the first circumferential ridge and the shoulder of the inwardly extending protrusion of the first connecting member when the first connecting member compresses the first conduit against the first end of the connector, and

wherein at least a portion of the second conduit is disposed between the shoulder of the inwardly extending protrusion of the second circumferential ridge and the shoulder of the second connecting member when the second connecting member compresses the second conduit against the second end of the connector.

2. The vascular access system of claim 1 , wherein the first and/or second conduits are configured with an impermeable wall segment in a portion nearest to the connector.

3. The vascular access system of claim 1 , wherein the first and/or second conduits are configured with an elastomeric wall segment to reduce bleeding after puncture or to improve sealing of the connector.

4. The vascular access system of claim 1 , further comprising a first therapeutic agent and a second therapeutic agent that are associated with one or both of an inner luminal surface and an outer abluminal surface of any of the first conduit, the second conduit, or the connector, wherein the vascular access system is configured to deliver a therapeutically effective dose of the first therapeutic agent and/or the second therapeutic agent to a mammal when the vascular access system is implanted within the mammal.

5. The vascular access system of claim 1 , wherein the first connecting member or the second connecting member further comprises at least one of snap fits, interfits, teeth, threaded connectors, key system, tension clips, seals, friction ridges, or any combination thereof.

6. The vascular access system of claim 1 , wherein the inside luminal wall of the connector is configured with a coating layer.

7. The vascular access system of claim 1 , wherein the first and/or second connecting members comprise at least one ridge that spans at least a portion of an exterior circumference of the connector.

8. The vascular access system of claim 7 , wherein the first connecting member further comprises securing devices and the second connecting member further comprises securing devices, and wherein the securing devices are configured to compress at least one of said conduits against said at least one ridge.

9. The vascular access system of claim 1 , wherein the first connecting member and the second connecting member are each configured to couple with multiple artificial conduits of varying outside diameter, such that coupling of one of the first connecting member and the second connecting member with an artificial conduit forms a fluid tight lumen between the artificial conduit and the connector, wherein the first conduit has a first outside diameter, wherein the second conduit has a second outside diameter, and wherein the second outside diameter is different from the first outside diameter.

10. The vascular access system of claim 1 , wherein the inside luminal wall of the connector comprises ridges that spiral along a length of the connector that are configured to enhance laminar flow.

11. The vascular access system of claim 1 , wherein the connector is irreversibly coupled to the first conduit and the second conduit.

12. A vascular access system, comprising:

a first conduit having a first outside diameter;

a second conduit having a second outside diameter, wherein the second outside diameter is different from the first outside diameter; and

a connector comprising an inside luminal wall, a first end, a second end, a first connecting member on the first end, and a second connecting member on the second end,

wherein the first connecting member and the second connecting member are each configured to couple with multiple artificial conduits of varying outside diameter, such that coupling of one of the first connecting member and the second connecting member with an artificial conduit forms a fluid-tight lumen between the artificial conduit and the connector,

wherein the connector being configured to couple to an end of the first conduit and to an end of the second conduit such that there is a continuous lumen from the first conduit to the second conduit,

wherein the first connecting member comprises a first set of securing devices and the second connecting member comprises a second set of securing devices,

wherein at least one of the first set of securing devices and the second set of securing devices is configured to compress at least one of the first conduit and the second conduit against at least one of the first end and the second end of the connector,

wherein the first set of securing devices and the second set of securing devices each comprise engaging teeth,

wherein when the at least one of the first set of securing devices and the second set of securing devices compresses the at least one of the first conduit and the second conduit against the at least one of the first end and the second end, some of the engaging teeth engage with one another and some of the engaging teeth remain unengaged wherein the connector comprises a flange disposed between the first end and the second end,

wherein the first end and the second end of the connector each comprise a circumferential ridge disposed adjacent the flange wherein each of the circumferential ridges comprise a shoulder oriented toward the flange,

wherein the first set of securing devices and the second set of securing devices each comprise a radially inwardly extending protrusion between the engaging teeth and the flange, comprising a shoulder oriented away from the flange,

wherein at least a portion of the first conduit is disposed between the shoulder of the circumferential ridge of the first end of the connector and the shoulder of the first set of securing devices when the first set of securing devices compresses the first conduit against the first end of the connector, and

wherein at least a portion of the second conduit is disposed between the shoulder of the circumferential ridge of the second end of the connector and the shoulder of the second set of securing devices when the second set of securing devices compresses the second conduit against the second end of the connector.

13. The vascular access system of claim 12 , wherein the first and/or second connecting members comprise at least one ridge that spans at least a portion of an exterior circumference of the connector.

14. The vascular access system of claim 13 , wherein the first set of securing devices and the second set of securing devices are configured to compress at least one of said conduits against said at least one ridge.

15. The vascular access system of claim 12 , wherein the first and/or second conduits are configured with an impermeable wall segment in a portion nearest to the connector.

16. The vascular access system of claim 12 , wherein the first and/or second conduits are configured with an elastomeric wall segment to reduce bleeding after puncture or to improve sealing of the connector.

17. The vascular access system of claim 12 , further comprising a first therapeutic agent and a second therapeutic agent that are associated with one or both of an inner luminal surface and an outer abluminal surface of any of the first conduit, the second conduit, or the connector, wherein the vascular access system is configured to deliver a therapeutically effective dose of the first therapeutic agent and/or the second therapeutic agent to a mammal when the vascular access system is implanted within the mammal.

18. The vascular access system of claim 12 , wherein the first connecting member or the second connecting member further comprises at least one of snap fits, interfits, teeth, threaded connectors, key system, tension clips, seals, friction ridges, or any combination thereof.

19. The vascular access system of claim 12 , wherein the connector irreversibly couples to the first or the second conduit with the first connecting member or the second connecting member further comprising at least one of snap fits, interfits, teeth, threaded connectors, key system, tension clips, seals, friction ridges, or any combination thereof.

20. The vascular access system of claim 12 , wherein the first conduit has different pliability than the second conduit.

21. The vascular access system of claim 12 , wherein the inside luminal wall of the connector comprises ridges that spiral along a length of the connector that are configured to enhance laminar flow.

Assignments (2)
SECURITY INTEREST Recorded Oct 1, 2018
From: MERIT MEDICAL SYSTEMS, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 047015/0301 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2018
From: HALL, JOHN; MOWER, WAYNE
To: MERIT MEDICAL SYSTEMS, INC.
Reel/Frame 046709/0374 →
Cited By (1)
US 12,564,422